Original ResearchFull Report: Clinical-Alimentary TractInfliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection
Keywords: PREVENT; Anti-TNF; Inflammatory Bowel Disease; CDAI; ARR; absolute risk reduction; ATI; antibodies to infliximab; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; TNF; tumor necrosis factor;